Avantor, Inc. Common Stock (NY:AVTR)

Securities Fraud Investigation Into Avantor, Inc. (AVTR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

October 31, 2025

From The Law Offices of Frank R. Cruz

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); DexCom, Inc. (NASDAQ: DXCM); Humana Inc. (NYSE: HUM); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf

October 31, 2025

From Grabar Law Office

Via GlobeNewswire

Earnings Scheduled For October 29, 2025 ↗

October 29, 2025

Via Benzinga

Avantor's Earnings Outlook ↗

October 28, 2025

Via Benzinga

What Analysts Are Saying About Avantor Stock ↗

October 24, 2025

Via Benzinga

AVANTOR, INC. (NYSE: AVTR) INVESTOR ALERT Investors With Large Losses in Avantor, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

October 31, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

1 Healthcare Stock with Impressive Fundamentals and 2 We Ignore

October 31, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

AVTR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor

Topics Stocks

October 30, 2025

From Faruqi & Faruqi, LLP

Avantor, Inc. (AVTR) Investors: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against Avantor, Inc. and Encourages Investors With Substantial Losses to Contact the Firm

October 30, 2025

From Kessler Topaz Meltzer & Check, LLP

Life sciences company Avantor (NYSE:AVTR) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.3% year on year to $1.62 billion. Its non-GAAP profit of $0.22 per share was...

AVTR Q3 Deep Dive: Strategic Overhaul Launched Amid Margin and Execution Challenges

October 30, 2025

Stocks fell as Fed Chair Powell warned a December rate cut is uncertain, citing data gaps and policy division.

Topics Economy

Stocks Slide As Powell Cools Rate-Cut Hopes: These 15 Stocks Are Feeling The Pinch ↗

October 29, 2025

Via Benzinga

Topics Economy

Avantor Plummets 17.4% as Disappointing Q3 Results and Impairment Charge Rock Investor Confidence

October 29, 2025

Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied...

Shares of life sciences company Avantor (NYSE:AVTR) fell 17.4% in the afternoon session after the company reported disappointing third-quarter 2025 results that missed revenue expectations and included...

Topics Artificial Intelligence Economy Supply Chain

Why Avantor (AVTR) Shares Are Trading Lower Today

October 29, 2025

Avantor stock fell after Q3 earnings and revenue missed estimates, leading the company to cut 2025 guidance but approve a $500 million buyback.

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 29, 2025

Via Benzinga

Avantor Struggles With Soft Demand But Backs Long-Term Value Through Buyback ↗

October 29, 2025

Via Benzinga

Avantor Inc (NYSE:AVTR) Stock Plummets 17% After Q3 Revenue Miss ↗

October 29, 2025

Avantor's Q3 2025 results missed revenue expectations, causing a sharp stock drop. While earnings per share met targets, sales fell 5.3% year-over-year.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 29, 2025

Via Benzinga

Avantor (NYSE:AVTR) Misses Q3 Sales Expectations, Stock Drops 17.9%

October 29, 2025

Life sciences company Avantor (NYSE:AVTR) will be announcing earnings results this Wednesday before market open. Here’s what investors should know.

Earnings To Watch: Avantor (AVTR) Reports Q3 Results Tomorrow

October 27, 2025

Shares of life sciences company Avantor (NYSE:AVTR) jumped 2.9% in the afternoon session after Bank of America Securities maintained its "Buy" rating on the company. This followed a similar move from...

Topics Artificial Intelligence

Avantor (AVTR) Stock Trades Up, Here Is Why

October 21, 2025

Since April 2025, Avantor has been in a holding pattern, posting a small return of 2.3% while floating around $15.30. The stock also fell short of the S&P 500’s 30.6% gain during that period.

Topics Artificial Intelligence

Avantor (AVTR): Buy, Sell, or Hold Post Q2 Earnings?

October 21, 2025

Shares of life sciences company Avantor (NYSE:AVTR) jumped 4.9% in the afternoon session after sentiment towards the stock improved following a series of positive developments, including an analyst...

Topics Stocks

Avantor (AVTR) Stock Is Up, What You Need To Know

October 03, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Avantor (NYSE:AVTR) and its peers.

Topics Government

Research Tools & Consumables Stocks Q2 Recap: Benchmarking Avantor (NYSE:AVTR)

October 02, 2025

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

Topics Economy

Deep Dive Into Avantor Stock: Analyst Perspectives (11 Ratings) ↗

October 02, 2025

Via Benzinga

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement...

Topics Artificial Intelligence Economy Government

Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma

September 30, 2025

Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility

Topics Artificial Intelligence Economy Government

September 30, 2025

As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move...

Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know

Topics Economy Government Supply Chain

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Topics Government

3 Cash-Producing Stocks We Keep Off Our Radar

September 05, 2025